These findings suggest that ISG15 dysregulation in bladder cancer does not appear to reflect a generalised inflammatory response as changes in pro- and anti-inflammatory markers between normal and tumour samples are insignificant. The gene discussed is ISG15; the disease is urinary bladder carcinoma.